Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: An updated analysis of the Japan Clinical Oncology Group Study JCOG0211

Journal of Clinical Oncology

Volumn 30, Issue 32, 2012, Pages 4044-4046

  Yamaguchi, Motoko ^a   Tobinai, Kensei ^b   Oguchi, Masahiko ^c   Ishizuka, Naoki ^d   Kobayashi, Yukio ^b   Isobe, Yasushi ^e   Ishizawa, Kenichi ^f   Maseki, Nobuo ^g   Itoh, Kuniaki ^h   Usui, Noriko ⁱ   Wasada, Izumi ^j   Kinoshita, Tomohiro ^k   Hotta, Tomomitsu ^l   Tsukasaki, Kunihiro ^m   Oshimi, Kazuo ⁿ  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOHOKU UNIVERSITY HOSPITAL   (Japan)

^g SAITAMA CANCER CENTER   (Japan)

^h NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

ⁱ JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOKAI UNIVERSITY   (Japan)

^k AICHI CANCER CENTER HOSPITAL   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^m NAGASAKI UNIVERSITY   (Japan)

ⁿ EISAI CO LTD   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE;

CANCER RADIOTHERAPY; CANCER SURVIVAL; CATARACT; CHEMORADIOTHERAPY; HUMAN; LETTER; MENSTRUAL IRREGULARITY; MULTIPLE CYCLE TREATMENT; NK T CELL LYMPHOMA; PERFORATION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIATION DOSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; NOSE NEOPLASMS;

EID: 84869456017     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.6541     Document Type: Letter

References (6)

1. Jaffe ES, Harris NL, Stein H, et al (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001
2. Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC, 2008
3. Yamaguchi M, Tobinai K, Oguchi M, et al: Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 27:5594-5600, 2009
4. Kim GE, Cho JH, Yang WI, et al: Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 18:54-63, 2000
5. Kim SJ, Kim K, Kim BS, et al: Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol 27:6027-6032, 2009
6. Foss FM, Zinzani PL, Vose JM, et al: Peripheral T-cell lymphoma. Blood 117:6756-6767, 2011